Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA
Published November 13, 2019 · Recall initiated: November 1, 2019
Summary
FDA records drug Class III recall D-0306-2020, published November 13, 2019 and initiated November 1, 2019. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: a) 4074 bottles b) 30,300 bottles; Lot: Lot #: a) F900153, Exp 11/20; b) F802327, F802328, F802329, Exp 11/20. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign substance: identified as a dead ant.
What to do
Voluntary: Firm initiated · Letter
Get an email if CEFDINIR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEFDINIR
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed to major distributors/wholesalers throughout the United States.
- UPC
- 0368180723042
- Lot
- Lot #: a) F900153, Exp 11/20; b) F802327, F802328, F802329, Exp 11/20
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: LupinJune 5, 2024
- FDACefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, ManufacturedMay 22, 2024
- FDACefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, ManufacturedMay 22, 2024
- FDACefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: LupinJuly 29, 2020
- FDACefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals,November 13, 2019
- FDAGreen Lumber Natural Fuel For Men capsule, packaged in packs of 2, 4 and 10 capsules, 2618 San Miguel Drive,November 13, 2019
Questions about this recall
Was Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA recalled?
Yes. FDA published recall D-0306-2020 on November 13, 2019. Reported hazard: Presence of Foreign substance: identified as a dead ant.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEFDINIR. UPC: 0368180723042.